AIFM2 and posterior cortical atrophy: While some studies report lower FSP1 levels in primary PCa tissues compared to benign prostate tissue, its expression is paradoxically and significantly elevated in high-risk subgroups, particularly those with advanced-stage disease [84,85,86].